Kasturi Pawar Author
Subjects of specialization
Affiliation
Dermaroller; Pacemaker; Cosmeticeuticals
Principal Scientist, Formulation and Product Development Department, Valeant Pharmaceuticals North America, Petaluma, CA 94954, USA
Kasturi Pawar Principal Scientist, Formulation and Product Development Department, Valeant Pharmaceuticals North America, Petaluma, CA 94954, USA |
Editorial Open Access
Author(s): Kasturi Pawar
Recently, the World Health Organization (WHO) has declared that Zika, a virus, which has been linked to birth defects and neurological complications, no longer constitutes an international emergency. However, it still remains a threat which calls for a long term efforts to address the issue through development of vaccines. Several ongoing clinical trials led by government and private pharmaceutical companies have shown a great promise in the treatment of Zika. Apart from these trials, there are also ongoing research on understanding the virus better, its transmission mode and future possibility of leveraging it in other disease treatments. This article provides an insight on these efforts and their findings.
... view moreĀ»